Funding Clinical Trials
Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
CIRM Clinical Dashboard
Disease Areas |
Investigator | Organization | Phase | Trial Status | Targeted Enrollment | Detail |
|---|---|---|---|---|---|---|
|
Stephanie Cherqui | University of California, San Diego | Phase 1/2 | Active, not recruiting | 6 | |
| Jeffrey Lawson | Humacyte, Inc. | Phase 3 | Active, not recruiting | 355 | ||
| Robert Lowsky | Stanford University | Phase 1 | Active, not recruiting | 15 | ||
| Jeffrey Lawson | Humacyte, Inc. | Phase 3 | Active, not recruiting | 240 | ||
| Daniel Brennan | Medeor Therapeutics, Inc. | Phase 3 | Active, not recruiting | 30 | ||
| Everett Meyer | Stanford University | Phase 1 | Recruiting | 22 |
